The most common expected side effects of Zarxio are aching in the bones or muscles and redness, swelling or itching at injection site. Serious side effects include spleen rupture; serious allergic reactions and acute respiratory distress.
Friday, March 6, 2015
The FDA Approved the First Biosimilar: Zarxio (filgrastim-sndz)
Zarxio, which is biosimilar to Neupogen, is a medication that boosts the production of white blood cells and helps to ward off infection in patients receiving strong chemotherapy for some tumors.
The most common expected side effects of Zarxio are aching in the bones or muscles and redness, swelling or itching at injection site. Serious side effects include spleen rupture; serious allergic reactions and acute respiratory distress.
The most common expected side effects of Zarxio are aching in the bones or muscles and redness, swelling or itching at injection site. Serious side effects include spleen rupture; serious allergic reactions and acute respiratory distress.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment